Analysts Cut Nike, Lift Datadog and AbbVie

Wall Street turned bearish on NKE Monday. The consensus on Nike was downgraded, with the average analyst target price slipping to $50.66 from $51.00. The move pushes the buy/hold/sell split to 3/24/12 — one of the more cautious reads on a Dow component right now. Nike carries a $50 billion market cap.

Canaccord Genuity took the opposite stance on DDOG. Analyst Kingsley Crane raised his target to $295 from $250. He maintained a Buy rating. Datadog is now an $88 billion business. The broader consensus sits at just 1 buy, 3 holds, and 42 sells — so Crane is swimming against the tide.

Guggenheim's Vamil Divan lifted his price target on ABBV to $288 from $261. He kept a Buy rating. AbbVie is a $443 billion pharma giant. The consensus remains skewed bearish, with only 1 buy versus 23 sells.

HD also saw a quiet positive consensus shift. The Home Depot's average target nudged up to $370.50. TROW got a similar small boost, with T. Rowe Price's average target rising to $109.83. Both moves reflect modest post-earnings revisions rather than full rating changes.